* Precigen Inc PGEN.OQ PGEN.O is expected to show a fall
in
quarterly revenue when it reports results on March 4
(estimated) for the period ending December 31 2023
* The Germantown Maryland-based company is expected to
report a
3.6% decrease in revenue to $1.7 million from $1.76 million a
year ago, according to the mean estimate from 4 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for Precigen Inc is for a
loss
of 8 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Precigen
Inc is
$9.00, above its last closing price of $1.54.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -0.08 -0.08 -0.08 Met -2.6
Jun. 30 2023 -0.10 -0.10 -0.08 Beat 20
Mar. 31 2023 -0.10 -0.09 -0.10 Missed -9.6
Dec. 31 2022 -0.10 -0.10 -0.11 Missed -10
Sep. 0.00 0.02 -0.04 Missed -340
30 2022
Jun. 30 2022 -0.15 -0.13 -0.09 Beat 31.8
Mar. 31 2022 -0.14 -0.13 -0.10 Beat 21.6
Dec. 31 2021 -0.14 -0.14 -0.13 Beat 4.4
This summary was machine generated March 1 at 11:28 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)